Amar Shah

Amar Shah is a distinguished professional in the fields of artificial intelligence and machine learning, currently serving as a Co-founding Advisor at CHARM Therapeutics since September 2021, where efforts focus on leveraging protein folding AI for drug discovery. Prior to this role, Amar was an Entrepreneur In Residence at firstminute capital, enhancing early-stage startup ventures through sourcing and mentoring. As Co-Founder and CEO of Wayve from July 2017 to September 2020, Amar pioneered advancements at the intersection of AI and mobile robotics. Additional experience includes a position as a Machine Learning Researcher at NASA Ames Research Center, working on planetary defense projects, and a role as a Quantitative Analyst at Goldman Sachs. Educational qualifications include a Postdoctoral Researcher position and a PhD in Machine Learning from the University of Cambridge, as well as a Master's degree in Mathematics from the same institution.